1,658
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Increased use of 6-monthly gonadotropin-releasing hormone agonist therapy for prostate cancer: a capacity and cost-minimization analysis for England

ORCID Icon, , , &
Pages 208-218 | Received 25 Nov 2022, Accepted 20 Jan 2023, Published online: 07 Feb 2023